This site is intended for healthcare professionals
News

Phase III Measure Up 1 and Measure Up 2 studies support applications to FDA and MAA for Rinvoq in atopic dermatitis.- AbbVie

Read time: 1 mins
Last updated:30th Oct 2020
Published:30th Oct 2020
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest